Vol. 1 No. 9 (2025), Articles
Vol. 1 No. 9 (2025)

ANTIBIOTIKLAR BILAN DAVOLASHNING JIDDIY SALBIY OQIBATLARI, ANTIBIOTIKLARGA QARSHI TURLI XIL KASALLIKLARNING RIVOJLANISHI, VA BU BORADA YANGI STRATEGIYALAR.

Articles
Published 2025-09-23
Anorov Sirojiddin
Alfraganus Universiteti Tibbiyot fakulteti Davolash ishi yoʻnalishi talabasi
PDF

Keywords

Antibiotiklar, dori chidamliligi, mikrobial rezistentlik, superinfeksiya, oqilona davolash, infektsiyalar, yondosh strategiyalar, probiotiklar, antimikrob profilaktika, sog‘liqni saqlash.

Abstract

Ushbu maqolada antibiotiklar bilan davolashning salbiy oqibatlari, xususan ularning haddan tashqari va noto‘g‘ri qo‘llanishi natijasida antibiotiklarga chidamli mikroorganizmlarning shakllanishi tahlil qilinadi. Bunday holatlar nafaqat bemorlarning sog‘lig‘iga, balki butun sog‘liqni saqlash tizimiga xavf tug‘diradi. Antibiotiklar samarasining pasayishi infektsion kasalliklarni davolashni qiyinlashtiradi, asoratlar va o‘lim holatlarining ortishiga olib keladi. Maqolada shuningdek, antibiotiklarga qarshi strategiyalar — shu jumladan yangi dori vositalarini ishlab chiqish, antibiotiklarni oqilona qo‘llash va mikrobial rezistentlikka qarshi xalqaro tashabbuslar yoritiladi.

PDF

References

1. World Health Organization. (2023). Antimicrobial resistance: Global report on surveillance. Geneva: WHO Press.

2. Davies, J., & Davies, D. (2010). Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, 74(3), 417–433.

3. Ventola, C. L. (2015). The antibiotic resistance crisis: causes and threats. Pharmacy and Therapeutics, 40(4), 277–283.

4. CDC (Centers for Disease Control and Prevention). (2023). Antibiotic Resistance Threats in the United States.

5. O'Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance.

6. Laxminarayan, R., et al. (2013). Antibiotic resistance—the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057–1098.

7. Klein, E. Y., et al. (2018). Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proceedings of the National Academy of Sciences, 115(15), E3463–E3470.

8. Spellberg, B., et al. (2016). The future of antibiotics and resistance: A tribute to a career of leadership by John Bartlett. Clinical Infectious Diseases, 63(7), 919–925.

9. Boucher, H. W., et al. (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical Infectious Diseases, 48(1), 1–12.

10. European Medicines Agency (EMA). (2022). Guidance on prudent use of antimicrobials in human health.